BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37068553)

  • 1. Roles of TGF-β signals in tumor microenvironment via regulation of the formation and plasticity of vascular system.
    Watabe T; Takahashi K; Pietras K; Yoshimatsu Y
    Semin Cancer Biol; 2023 Jul; 92():130-138. PubMed ID: 37068553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment.
    Takahashi K; Kobayashi M; Katsumata H; Tokizaki S; Anzai T; Ikeda Y; Alcaide DM; Maeda K; Ishihara M; Tahara K; Kubota Y; Itoh F; Park J; Takahashi K; Matsunaga YT; Yoshimatsu Y; Podyma-Inoue KA; Watabe T
    Cancer Sci; 2024 Feb; 115(2):490-506. PubMed ID: 38111334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance.
    Platel V; Faure S; Corre I; Clere N
    J Oncol; 2019; 2019():8361945. PubMed ID: 31467544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy.
    Yin Z; Wang L
    Ann Med; 2023 Dec; 55(1):1058-1069. PubMed ID: 36908260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.
    Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T
    Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease.
    Yoshimatsu Y; Watabe T
    Inflamm Regen; 2022 Feb; 42(1):9. PubMed ID: 35130955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of hypoxia on early endothelial-mesenchymal transition response to transforming growth beta isoforms 1 and 2.
    Doerr M; Morrison J; Bergeron L; Coomber BL; Viloria-Petit A
    Microvasc Res; 2016 Nov; 108():48-63. PubMed ID: 27503671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction.
    Haynes BA; Yang LF; Huyck RW; Lehrer EJ; Turner JM; Barabutis N; Correll VL; Mathiesen A; McPheat W; Semmes OJ; Dobrian AD
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2168-2191. PubMed ID: 31434495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proactive and reactive roles of TGF-β in cancer.
    Kuburich NA; Sabapathy T; Demestichas BR; Maddela JJ; den Hollander P; Mani SA
    Semin Cancer Biol; 2023 Oct; 95():120-139. PubMed ID: 37572731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2.
    Nie L; Lyros O; Medda R; Jovanovic N; Schmidt JL; Otterson MF; Johnson CP; Behmaram B; Shaker R; Rafiee P
    Am J Physiol Cell Physiol; 2014 Nov; 307(9):C859-77. PubMed ID: 25163519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
    Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
    J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Good RB; Gilbane AJ; Trinder SL; Denton CP; Coghlan G; Abraham DJ; Holmes AM
    Am J Pathol; 2015 Jul; 185(7):1850-8. PubMed ID: 25956031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1.
    Akatsu Y; Takahashi N; Yoshimatsu Y; Kimuro S; Muramatsu T; Katsura A; Maishi N; Suzuki HI; Inazawa J; Hida K; Miyazono K; Watabe T
    Mol Oncol; 2019 Aug; 13(8):1706-1724. PubMed ID: 31094056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.
    Wei WF; Zhou HL; Chen PY; Huang XL; Huang L; Liang LJ; Guo CH; Zhou CF; Yu L; Fan LS; Wang W
    J Exp Clin Cancer Res; 2023 Jul; 42(1):160. PubMed ID: 37415190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.
    Junk DJ; Cipriano R; Bryson BL; Gilmore HL; Jackson MW
    Neoplasia; 2013 Sep; 15(9):1100-9. PubMed ID: 24027434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-β-induced endothelial to mesenchymal transition.
    Bijkerk R; de Bruin RG; van Solingen C; Duijs JM; Kobayashi K; van der Veer EP; ten Dijke P; Rabelink TJ; Goumans MJ; van Zonneveld AJ
    Microrna; 2012; 1(1):2-10. PubMed ID: 25048084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β signaling promotes tumor vasculature by enhancing the pericyte-endothelium association.
    Zonneville J; Safina A; Truskinovsky AM; Arteaga CL; Bakin AV
    BMC Cancer; 2018 Jun; 18(1):670. PubMed ID: 29921235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.
    Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS
    J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT).
    Abu El-Asrar AM; De Hertogh G; van den Eynde K; Alam K; Van Raemdonck K; Opdenakker G; Van Damme J; Geboes K; Struyf S
    Exp Eye Res; 2015 Mar; 132():179-89. PubMed ID: 25637870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.